Tag: Biofourmis
Biofourmis Buys Biovotion to Deliver Precise Interventions for Patients with Complex Chronic Conditions
US-based digital therapeutics company Biofourmis has signed an agreement to buy Zurich, Switzerland-based wearable biosensor company Biovotion. The deal consists of all Biovotion’s assets,...
Biofourmis to Partner with Yale University-Mayo Clinic Collaborative Program CERSI
Biofourmis, a global leader in digital therapeutics, has entered a research partnership with Yale University-Mayo Clinic Center of Excellence in Regulatory Science and Innovation...
FDA Clears Biofourmis’ AI-Driven Arrhythmia Detection Platform RhythmAnalytics
Biofourmis, a Singapore-based health-tech startup, has received FDA clearance for its cloud-based software, RhythmAnalytics, which helps healthcare professionals in detecting cardiac arrhythmia, or irregular...